Laboratory Animal Sciences 2019

Digital transformation has affected the clinical phase of the drug development journey by improving efficiencies, patient engagement and allowing for utilization of computational and other technologies. This track will address topics such as data collection, flow, storage and analytics and digital transformation case studies in clinical phase and the potential for digital transformation in the preclinical phase.  Preclinical in vivo phase is in the initial stages of engaging with digitization and digitalization, which presents opportunities for learning from clinical colleagues how to implement these technologies.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Subcellular sphingolipids and ceramides in organelle function

The subcellular distribution and function of lipids remains a serious challenge to understanding biology. Two student presentations at a recent scientific conference highlighted a new innovation in mass spectrometry that improves organelle identification and a new function for ceramide-dependent mitophagy associated with aging in T cells.
Watch Now

Gene Therapy for Rare Diseases

quanticate

There are approximately 7,000 distinct rare diseases affecting 350 million people worldwide, approximately 80 percent of which are caused by faulty genes.
Watch Now

Measuring Multivalent Interactions: Uncovering the Secrets of Virus Binding Strategies

genengnews

Influenza A virus (IAV) utilizes a multivalent binding strategy to the host cell, binding its trimeric spike protein hemagglutinin (HA) to sialic acid present on the cellular membrane.
Watch Now

Studying protein polymerization with mass photometry

Protein polymerization underpins major biological processes, such as cell division and intracellular transport, while undesired assembly can lead to protein aggregates that are associated with, for example, neurodegenerative diseases and cancer.
Watch Now

Spotlight

resources